<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jin B</submitter><funding>BLRD VA</funding><funding>United States Department of Veterans Affairs</funding><pagination>1976</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9405709</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(8)</volume><pubmed_abstract>Patients with psoriasis tend to develop skin cancer, and the hyperproliferation of the epidermis is a histopathological hallmark of both psoriasis and cutaneous squamous cell carcinoma (SCC), indicating that they may share pathogenic mechanisms. Interleukin-17 (IL17) stimulates the proliferation of the epidermis, leading to psoriasis. Overexpression of Polo-like kinase 4 (PLK4), which controls centriole duplication, has been identified in SCC, which also shows the hyperproliferation of keratinocytes. To investigate the cooperation between IL17 signaling and centriole duplication in epidermal proliferation, we established psoriasis and skin papilloma models in wild type (WT), IL17 receptor A (T779A) knockin (&lt;i>Il17ra&lt;/i>(T779A)-KI), and IL17 receptor C knockout (&lt;i>Il17rc&lt;/i>-KO) mouse str</pubmed_abstract><journal>Biomedicines</journal><pubmed_title>Defect of IL17 Signaling, but Not Centrinone, Inhibits the Development of Psoriasis and Skin Papilloma in Mouse Models.</pubmed_title><pmcid>PMC9405709</pmcid><funding_grant_id>I01 BX004158</funding_grant_id><funding_grant_id>I01BX004158</funding_grant_id><pubmed_authors>Miller HD</pubmed_authors><pubmed_authors>Ge D</pubmed_authors><pubmed_authors>You Z</pubmed_authors><pubmed_authors>Jin B</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>He L</pubmed_authors><pubmed_authors>Wang AR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defect of IL17 Signaling, but Not Centrinone, Inhibits the Development of Psoriasis and Skin Papilloma in Mouse Models.</name><description>Patients with psoriasis tend to develop skin cancer, and the hyperproliferation of the epidermis is a histopathological hallmark of both psoriasis and cutaneous squamous cell carcinoma (SCC), indicating that they may share pathogenic mechanisms. Interleukin-17 (IL17) stimulates the proliferation of the epidermis, leading to psoriasis. Overexpression of Polo-like kinase 4 (PLK4), which controls centriole duplication, has been identified in SCC, which also shows the hyperproliferation of keratinocytes. To investigate the cooperation between IL17 signaling and centriole duplication in epidermal proliferation, we established psoriasis and skin papilloma models in wild type (WT), IL17 receptor A (T779A) knockin (&lt;i>Il17ra&lt;/i>(T779A)-KI), and IL17 receptor C knockout (&lt;i>Il17rc&lt;/i>-KO) mouse str</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-27T02:29:42.228Z</modification><creation>2024-11-21T06:49:39.675Z</creation></dates><accession>S-EPMC9405709</accession><cross_references><pubmed>36009523</pubmed><doi>10.3390/biomedicines10081976</doi></cross_references></HashMap>